Sun, 29-May-2022

Novartis

Novartis Kymriah Receives FDA Regenerative Medicine ...

Novartis today announced that the US Food and Drug Administration (FDA) granted Regenerative Medicine Advanced Therapy (RMAT) designation to Kymriah (tisagenlecleucel), for an investigational new indication t... April 22, 2020 6:37 am By Neha Mule

FDA Permits Novartis to Conduct a Randomized Trial o...

Novartis has won the go-ahead from the U.S. Food and Drug Administration (FDA) to conduct a randomized trial of malaria drug hydroxychloroquine against COVID-19 disease, the Swiss drugmaker said on Monday, to ... April 20, 2020 8:54 am By Neha Mule

Voluntis Collaborates with Novartis to Evaluate the ...

Voluntis announced today a collaboration with Novartis to evaluate the use of Voluntis’ digital therapeutic platform for Breast Cancer patients with the goal to empower patients with tools to more effectivel... December 19, 2019 11:33 am By Neha Mule

Related News